HORIZON FVF3426g
Posted by: Georgia Retina in
Research Title: An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO Sponsor: Genentech Principal Investigator: Jay Stallman, M.D. Description: This is an open-label, multicenter, extension study of intravitreally administered ranibizumab in subjects with primary or recurrent CNV secondary to AMD who have completed…
Read More
AART C-02-60
Posted by: Georgia Retina in
Research Title: Anecortave Acetate Risk-Reduction Trial (AART) Sponsor: Allergan Principal Investigator: Atul Sharma, M.D. Description: A 48-month study of posterior juxtascleral administrations of Anecortave Acetate 15 or 30 mg or sham administration every 6 months. Start Date: March 2006 Recruitment: Completed Project Personnel: Leslie Marcus, CCRC Location(s): Riverdale; 155 Medical Way, Suite E, Riverdale, GA 30274
Read More Allergan 1771-201-008 MAPLE
Posted by: Georgia Retina in
Research Title: Evaluating Abicipar for Safety and Treatment Effect in Patients With Neovascular Age-related Macular Degeneration (AMD) Sponsor: Allergan Principal Investigator: Robert Stoltz, M.D., Ph.D. Description: The objective of this study is to evaluate abicipar for safety and treatment effect in patients with neovascular Age-related Macular Degeneration (AMD). Start Date: June 2018 Recruitment: Enrolling Project Personnel: Leslie Marcus, CCRC; Caitlin Harrison, CCRC,…
Read More ALLERGAN 206207-012
Posted by: Georgia Retina in
Research Title: Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema Sponsor: Allergan Principal Investigator: Robert Stoltz, M.D., Ph.D Description: This study will evaluate the safety and efficacy of the intravitreal implant of dexamethasone with laser treatment vs. laser treatment alone in patients with diabetic macular edema. Start Date: April 2007 Recruitment: Completed Project Personnel: Leslie…
Read More AREDS2
Posted by: Georgia Retina in
Research Title: Age-Related Eye Disease Study 2 (AREDS2) Sponsor: National Eye Institute (NEI) Principal Investigator: Jay Stallman, M.D. Description: AREDS2 is a multi-center randomized trial of approximately 4,200 participants designed to assess the effects of oral supplementation of high doses of macular xanthophylls (lutein and zeaxanthin) and omega-3 LCPUFAs (DHA and EPA) for the treatment of AMD and cataract….
Read More Acucela 4429-202 SEATTLE
Posted by: Georgia Retina in
Research Title: A Phase 2b/3 Multicenter, Randomized, Double-Masked, Dose-Ranging Study Comparing the Efficacy and Safety of Emixustat Hydrochloride (ACU-4429) With Placebo for the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration. Sponsor: Acucela Inc Principal Investigator: Mark J. Rivellese, M.D. Description: The purpose of this study is to determine if emixustat hydrochloride (ACU-4429) reduces the rate of…
Read More Aerpio AKB-9778-CI-5001 TIME-2b
Posted by: Georgia Retina in
Research Title: Phase 2 Double-Masked, Placebo-Controlled Study to Assess the Safety and Efficacy of Subcutaneously Administered AKB-9778 15mg Once Daily or 15mg Twice Daily for 12 Months in Patients With Moderate to Severe Non-Proliferative Diabetic Retinopathy Sponsor: Aerpio Therapeutics, LLC Principal Investigator: Sri Krishna Mukkamala, M.D. Description: The purpose of this study is to evaluate the safety and efficacy…
Read More Allergan 150998-005 CEDAR
Posted by: Georgia Retina in
Research Title: A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-Related Macular Degeneration Sponsor: Allergan Principal Investigator: Robert A. Stoltz, M.D., Ph.D. Description: This is a safety and efficacy study of abicipar pegol in patients with neovascular age-related macular degeneration. Start Date: October 2015 Recruitment: Complete Project Personnel: Leslie Marcus, CCRC; Caitlin Harrison, CCRC, COA; Stephanie Campbell, CRC,…
Read More Allergan 190342-038 BEACON
Posted by: Georgia Retina in
Research Title: A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration. Sponsor: Allergan Principal Investigator: Mark J. Rivellese, M.D. Description: This study will assess the safety and efficacy of the brimonidine intravitreal implant in patients with geographic atrophy due to age-related macular degeneration. Start Date: December 2015 Recruitment: Completed Project Personnel: Leslie Marcus, CCRC;…
Read More AREDS2 ForeseeHome
Posted by: Georgia Retina in
Research Title: Home Vision Monitoring in Age-Related Eye Disease 2 (AREDS2) Using the ForeseeHome Device Sponsor: Notal Vision, Ltd. Principal Investigator: Jay Stallman, M.D. Description: The overall objective of this two arm randomized clinical trial (RCT) is to determine if home monitoring using the comprehensive visual field and telemedicine solution based on the ForeseeHome device in AREDS2 improves detection…
Read More 
